Seri S. Park

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington’s disease”.

PAM-altering SNP-based allele-specific CRISPR-Cas9 therapeutic strategies for Huntington’s disease

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.08.005

N/A

0.651DataRank · unranked

17 citations

Eun Pyo Hong, Seri S. Park, Doo Eun Choi, Sophia Zeng, Richard Z. Chen +2 more

Allele-specific silencing of the gain-of-function mutation in Huntington’s disease using CRISPR/Cas9

JCI Insight(2022)10.1172/jci.insight.141042

N/A

0DataRank · unranked

34 citations

Eun Pyo Hong, Seri S. Park, Doo Eun Choi, Ihn Sik Seong, Madelynn N. Whittaker +4 more

Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease

Molecular Therapy — Methods & Clinical Development(2022)10.1016/j.omtm.2022.03.001

N/A

0DataRank · unranked

11 citations

Aram Shin, Seri S. Park, Jong-Min Lee, Jun Wan Shin

Significant underascertainment in Huntington’s disease

Brain Communications(2025)10.1093/braincomms/fcaf194

N/A

0DataRank · unranked

2 citations

Ben Weisburd, Jiwoo Lee, Kevin Correia, Sophia Zeng, Seri S. Park +10 more